CD8A and neoplasm: These results suggested that tumor cell-derived ILT4 prevented the infiltration of tumoricidal cytotoxic CD8+ T cells and recruited tumor-suppressive Tregs, which are responsible for ILT4-impaired anti-tumor immune response.